Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ICN Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Clouseau who wrote (839)	5/4/1998 11:18:00 PM
From: IRWIN JAMES FRANKEL	Read Replies (1) \| Respond to of 1029

Did the panel comment on the combined packaging issue? Teratogenic has something to do with ill effects of a drug in pregnant women. I think that drugs that are declared to be teratogenic are restricted as to use by pregnant or women in child bearing risk. (I'm not trained in science, so the explanation is crude.) I have been in ICN a long time too. I started buying at 13 presplit and continued up to 28 leaving me with an average price of 20 (13.33 on current stock). Thanks for the additional info. Do you live in the DC area or travel there for the hearing? Jim